2017
DOI: 10.7705/biomedica.v37i3.3437
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic accuracy of three technologies for the diagnosis of multi-drug resistant tuberculosis

Abstract: : estructuración del manuscrito, aportes a resultados y discusión María de los Ángeles Carrasquilla: discusión sobre la metodología y análisis de la información Verónica Jhajaira Gómez y Jaime Robledo: redacción del manuscrito y discusión de los resultados Todos los autores participaron en la selección de los estudios publicados.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 35 publications
0
3
0
Order By: Relevance
“…studies (participants) PTB, summary estimates (95% CI) No. studies Rifampicin resistance, summary estimates (95% CrI) Sensitivity Specificity Sensitivity Specificity Chang 2012October201115 (8117)90% (89 to 91)98% (98 to 99)7see notesee noteWalusimbi 2013b(smear‐negative)May 201215 (2046)67% (62 to 71)98% (97 to 99)NANANASteingart 2014December 201327 (6026)89% (85 to 92)99% (98 to 99)sensitivity: 17 specificity: 2495% (90 to 97)98% (97 to 99)Yan 2016not reported12 (8122)89% (87 to 90)98% (98 to 99)NANANALi 2017June 201524 (2486)87% (83 to 90)97% (96 to 98)NANANAAlvis‐Zakzuk 2017December 2015NANANA8see notesee noteHorne 2019January 201885 (41,965)85% (82 to 87)98% (97 to 98)48 (8020)96% (94 to 97)98% (98 to 99)Abbreviations: CI: confidence interval; Crl: credible interval; NA: not applicable; PTB: pulmonary tuberculosis.Chang 2012 inc...…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…studies (participants) PTB, summary estimates (95% CI) No. studies Rifampicin resistance, summary estimates (95% CrI) Sensitivity Specificity Sensitivity Specificity Chang 2012October201115 (8117)90% (89 to 91)98% (98 to 99)7see notesee noteWalusimbi 2013b(smear‐negative)May 201215 (2046)67% (62 to 71)98% (97 to 99)NANANASteingart 2014December 201327 (6026)89% (85 to 92)99% (98 to 99)sensitivity: 17 specificity: 2495% (90 to 97)98% (97 to 99)Yan 2016not reported12 (8122)89% (87 to 90)98% (98 to 99)NANANALi 2017June 201524 (2486)87% (83 to 90)97% (96 to 98)NANANAAlvis‐Zakzuk 2017December 2015NANANA8see notesee noteHorne 2019January 201885 (41,965)85% (82 to 87)98% (97 to 98)48 (8020)96% (94 to 97)98% (98 to 99)Abbreviations: CI: confidence interval; Crl: credible interval; NA: not applicable; PTB: pulmonary tuberculosis.Chang 2012 inc...…”
Section: Discussionmentioning
confidence: 99%
“…Li 2017 106 studies (52,410 specimens) for both PTB and extrapulmonary tuberculosis. Alvis‐Zakzuk 2017 2017 summarized accuracy of Xpert for detection of rifampicin resistance, sensitivity range 33% to 100%; specificity range 91% to 100%. Horne 2019 is this updated Cochrane Review.Systematic reviews not included in this table:Kaur 2016 did not provide summary sensitivity and specificity estimates.…”
Section: Discussionmentioning
confidence: 99%
“…That year, 3.6% of new patients and 18% of retreated patients developed RFP-resistant or multidrug-resistant tuberculosis (MDR-TB), and 450,000 patients developed drug-resistant TB (DR-TB) [ 1 ]. DR-TB, especially MDR-TB, poses many problems during diagnosis and treatment and is one of the main challenges affecting global TB prevention and control [ 2 , 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%